PIM
HRMY icon

Platinum Investment Management’s Harmony Biosciences HRMY Stock Holding History

Platinum Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,315
Closed -$43.1K – 150
2023
Q3 		$43.1K Hold
1,315
– – ﹤0.01% 138
2023
Q2 		$46.3K Hold
1,315
– – ﹤0.01% 138
2023
Q1 		$42.9K Buy
+1,315
New +$59.9K ﹤0.01% 142

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Platinum Investment Management's HRMY Position: Q4 2023 in Review

Platinum Investment Management sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 1,315 shares — an estimated $43.1K sold.

Platinum Investment Management first reported a position in HRMY in Q1 2023 and held it in 3 quarters. The position peaked at $46.3K in Q2 2023. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

  • Platinum Investment Management reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
  • Platinum Investment Management sold 1,315 Harmony Biosciences shares in Q4 2023, an estimated $43.1K.
  • Platinum Investment Management first reported a position in Harmony Biosciences in Q1 2023 and held it in 3 quarters.
  • Platinum Investment Management's Harmony Biosciences position peaked at $46.3K in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Platinum Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.